However, total hospital deal value rose from $320 million in the first quarter of 2013 to $388 this year, according to the report. That increase was largely driven by the $369 million acquisition of Bethesda, Md.-based Chindex International announced in February, according to the report. Chindex is an American company that provides services in China through a network of private primary care hospitals and affiliated ambulatory clinics.
Overall, the softened deal activity during the first quarter “doesn’t necessarily indicate a slowdown,” according to the report. “Hospitals (both for-profit and not-for-profit) across many geographies within the U.S. continue to assess strategic alternatives, specifically addressing their market position, long-term strategy and the recent large transactions which have reinforced a ‘bigger is better’ mentality within the hospital sector,” the report states.
More Articles on Hospital Transactions:
CHS Calls Off Bert Fish Merger Deal
Massachusetts Approves Partners’ Acquisitions, But With Conditions
7 Recent Hospital Transactions and Partnerships
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
